PLoS ONE · 2017 · 36 citations · 37 references
Life SciencesGeneticsMicrobiologyBacteriologyMedical MicrobiologyMicrobial GeneticsBacterial GeneticsBacterial IdentificationBacterial InfectionsBacterial PathogenesisPathogen DetectionPathogen GenomicsClinical Outcome MeasurementConcordance AssessmentQuantitative Pcr DetectionResistance In Clinical IsolatesResistance Mechanisms In StaphylococciStaphylococcus Aureus Control
OBJECTIVE: Characterization of Staphylococcus aureus clinical isolates derived from lower respiratory tract infections (LRTIs), and correlation between the functionality of the accessory gene regulator (Agr) and genotypic and phenotypic characteristics, clinical variables and clinical outcome. METHODS: S aureus isolates derived from LRTIs and control groups (nasal carriage and bacteraemia) were genotyped using StaphyType DNA microarray. Agr activity was evaluated using the CAMP synergistic haemolysis assay and the Vesicle Lysis Test (VLT). Discordant strains were analysed by quantitative reverse-transcriptase real-time PCR (qRT-PCR). RESULTS: Agr was functional in 79.7% and 84.5% of strains according to the CAMP and VLT assays respectively. Higher concordance with RNAIII expression measured by qRT-PCR was observed with the VLT assay (76.2%) compared with the CAMP assay (23.8%). No statistically significant differences were observed in Agr functionality between the study groups, nor the phenotypical/genotypical bacterial characteristics. No association between increased mortality/respiratory complications and Agr function was observed. CONCLUSIONS: Agr activity was high (82.2%) in isolates from LRTIs suggesting the importance of this global regulator in lower respiratory tract colonisation and infection. However, equally high Agr activity was observed in isolates derived from nasal carriage and bacteraemia, contradictory to previous observations. Agr functionality measured by the VLT assay was superior to CAMP assay.
37
Daniel J. Diekema, Michael A. Pfaller, Franz‐Josef Schmitz et al. · Clinical Infectious Diseases · 2001 · 1.4K citations
Shu Y. Queck, Max Jameson‐Lee, Amer E. Villaruz et al. · Molecular Cell · 2008 · 583 citations · Full text
Lorena Tuchscherr, Eva Medina, Muzaffar Hussain et al. · EMBO Molecular Medicine · 2011 · 436 citations · Full text